Jaarboek no. 89. 2010/2011 - Koninklijke Maatschappij voor ...
Jaarboek no. 89. 2010/2011 - Koninklijke Maatschappij voor ...
Jaarboek no. 89. 2010/2011 - Koninklijke Maatschappij voor ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Natuurkundige <strong>voor</strong>drachten I Nieuwe reeks 89<br />
Migraine: de ontrafeling van een complexe ziekte<br />
114<br />
‘<strong>no</strong>rmal’ migraine with or without aura.<br />
Thus, from a clinical perspective, FHM seems a<br />
valid model for the common forms of migraine both<br />
with and without aura.<br />
However, it bears mentioning that in 20% of cases,<br />
FHMmay also be associated with cerebellar ataxia<br />
and other neurological symptoms such as epilepsy,<br />
mental retardation, brain edema, and (sometimes<br />
fatal) coma. To date, three genes for FHM have<br />
been identified, and, based on unpublished linkage<br />
results in several families, there are likely more to<br />
come. These genes are discussed below.<br />
A. The FHM1 CACNA1A gene<br />
In 1996, the first gene linked to FHM was identified<br />
as the CACNA1A gene on chromosome 19p13.<br />
Responsible for approximately half of all families<br />
with FHM, the FHM1 gene encodes the ion-conducting,<br />
poreforming α1A subunit of CaV2.1, a neuronal<br />
voltage-gated calcium channel. The main function<br />
of CaV2.1 (P/Q-type) calcium channels is to trigger<br />
the release of neurotransmitters, both at central<br />
synapses and at the neuromuscular junction. Over<br />
50 mutations in CACNA1A have been associated<br />
with a wide range of clinical phe<strong>no</strong>types, including<br />
both pure FHM and combinations of FHM with<br />
various degrees of cerebellar ataxia and fatal coma<br />
due to excessive cerebral edema. Mutations in the<br />
CACNA1A gene have also been linked to disorders<br />
<strong>no</strong>t associated with FHM, including episodic ataxia<br />
type 2 (EA2), progressive ataxia, spi<strong>no</strong>cerebellar<br />
ataxia type 6, and both absence and generalized<br />
epilepsy. Interestingly, in several FHM families,<br />
FHM1 CACNA1A mutations were also found in family<br />
members who did <strong>no</strong>t exhibit FHM but instead<br />
exhibited ‘<strong>no</strong>rmal’ <strong>no</strong>nparetic migraine, suggesting<br />
that gene mutations for FHM may also be responsible<br />
for the common forms of migraine, possibly due<br />
to the contributions of different genetic and <strong>no</strong>ngenetic<br />
modulatory factors.<br />
B. The FHM2 ATP1A2 gene<br />
The second gene identified for FHM does <strong>no</strong>t code<br />
for an ion channel, but rather for a transporter that<br />
catalyzes the exchange of Na + and K + across the<br />
cell membrane. The ATP1A2 gene on chromosome<br />
1q23 encodes the α2 subunit of a Na + /K + -ATPase.<br />
This enzyme utilizes ATP hydrolysis to transport Na +<br />
ions out of the cell in exchange for K + ions into the<br />
cell, thereby providing the steep Na + gradient essential<br />
for the transport of glutamate and Ca2+ . During<br />
development, ATP1A2 is predominantly expressed in<br />
neurons, but expression shifts to glial cells by adulthood.<br />
In adults, an important function of this specific<br />
ATPase is to modulate the removal of potassium and<br />
glutamate from the synaptic cleft into the glial cell.<br />
Mutations in the ATP1A2 gene cause at least 20%<br />
of FHM cases and have been associated with pure<br />
FHM, as well as with FHM together with cerebellar<br />
ataxia, alternating hemiplegia of childhood, benign<br />
familial infantile convulsions and other forms of<br />
epilepsy. Interestingly, in an Italian family, a variant<br />
in the ATP1A2 gene segregated with basilar<br />
migraine, a subtype of MA characterized by aura<br />
symptoms attributable to the brainstem and both<br />
occipital lobes. However, <strong>no</strong> functional studies were<br />
reported, precluding a definite conclusion as to<br />
whether this gene variation is also causally linked<br />
to basilar migraine. It is also interesting to <strong>no</strong>te that<br />
ATP1A2 variants were identified in two <strong>no</strong>n-FHM<br />
migraine families, suggesting that this genemay<br />
play an important role in the susceptibility to common<br />
forms of migraine.<br />
C. The FHM3 SCN1A gene<br />
The most recent FHM gene identified is SCN1A on<br />
chromosome 2q24.<br />
This gene encodes the α subunit of a neuronal<br />
NaV1.1 sodium channel. Voltage-gated sodium channels<br />
are primarily responsible for the generation and<br />
propagation of action potentials in excitable cells. In<br />
the brain, NaV1.1 channels are expressed primarily on<br />
inhibitory neurons, and their absence leads to severe<br />
ataxia and seizures, presumably due to increased<br />
neuronal excitability. Different mutations in SCN1A<br />
are k<strong>no</strong>wn to be associated with childhood epilepsy<br />
and febrile seizures.<br />
D. Sporadic hemiplegic migraine (SHM)<br />
Hemiplegic migraine patients are <strong>no</strong>t always clus-